The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALKERMES PLC | SHS | G01767105 | 173,294 | 3,166,348 | SH | DFND | 1 | 0 | 3,166,348 | 0 | |
ALKERMES PLC | SHS | G01767105 | 80,024 | 1,462,163 | SH | DFND | 2 | 0 | 1,462,163 | 0 | |
ALKERMES PLC | SHS | G01767105 | 88,402 | 1,615,238 | SH | DFND | 3 | 0 | 1,615,238 | 0 | |
ALKERMES PLC | SHS | G01767105 | 42,679 | 779,810 | SH | DFND | 5 | 0 | 779,810 | 0 | |
ALKERMES PLC | SHS | G01767105 | 30,765 | 562,124 | SH | DFND | 0 | 301,189 | 260,935 | ||
BIOGEN INC | Common | 09062X103 | 35,780 | 112,313 | SH | DFND | 2 | 0 | 112,313 | 0 | |
BIOGEN INC | Common | 09062X103 | 49,108 | 154,151 | SH | DFND | 3 | 0 | 154,151 | 0 | |
BIOGEN INC | Common | 09062X103 | 24,647 | 77,369 | SH | DFND | 5 | 0 | 77,369 | 0 | |
BIOGEN INC | Common | 09062X103 | 8,516 | 26,731 | SH | DFND | 0 | 26,731 | 0 | ||
BIOVERATIV INC | Common | 09075E100 | 26,352 | 488,732 | SH | DFND | 2 | 0 | 488,732 | 0 | |
BIOVERATIV INC | Common | 09075E100 | 41,248 | 764,986 | SH | DFND | 3 | 0 | 764,986 | 0 | |
BIOVERATIV INC | Common | 09075E100 | 22,498 | 417,248 | SH | DFND | 5 | 0 | 417,248 | 0 | |
BIOVERATIV INC | Common | 09075E100 | 14,955 | 277,359 | SH | DFND | 0 | 147,009 | 130,350 | ||
GILEAD SCIENCES INC | Common | 375558103 | 36,479 | 509,197 | SH | DFND | 2 | 0 | 509,197 | 0 | |
GILEAD SCIENCES INC | Common | 375558103 | 45,514 | 635,310 | SH | DFND | 3 | 0 | 635,310 | 0 | |
GILEAD SCIENCES INC | Common | 375558103 | 22,944 | 320,263 | SH | DFND | 5 | 0 | 320,263 | 0 | |
GILEAD SCIENCES INC | Common | 375558103 | 8,209 | 114,583 | SH | DFND | 0 | 114,583 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 288,103 | 7,684,790 | SH | DFND | 1 | 0 | 7,684,790 | 0 | |
PROTHENA CORP PLC | SHS | G72800108 | 95,615 | 2,550,408 | SH | DFND | 4 | 0 | 2,550,408 | 0 | |
PROTHENA CORP PLC | SHS | G72800108 | 48,490 | 1,293,416 | SH | DFND | 0 | 708,342 | 585,074 | ||
THERAVANCE BIOPHARMA INC | Common | G8807B106 | 226,326 | 8,114,946 | SH | DFND | 1 | 0 | 8,114,946 | 0 | |
THERAVANCE BIOPHARMA INC | Common | G8807B106 | 39,824 | 1,427,893 | SH | DFND | 4 | 0 | 1,427,893 | 0 | |
THERAVANCE BIOPHARMA INC | Common | G8807B106 | 33,587 | 1,204,269 | SH | DFND | 0 | 421,270 | 782,999 |